Smiling female scientist wearing safety glasses in a laboratory

Built around
your molecule
Overview

A dedicated U.S. biologics CDMO with 30+ years of development and manufacturing expertise built to help complex therapies reach the people who need them.

NUMBERS

Who We Are

Avid Bioservices is a dedicated biologics contract development and manufacturing organization (CDMO), focused
entirely on helping biotech and pharmaceutical companies bring innovative therapies to market.

From our facilities in Southern California, we combine scientific expertise, integrated capabilities, and a partnership-driven
approach to support programs from early development through commercial supply.

0  +

Years of biologics manufacturing expertise

0  +

Biological batches manufactured

0  +

Countries globally
where products are approved and marketed

Close-up of a pipette dispensing liquid into a laboratory sample vial
Two colleagues talking in a laboratory, one wearing glasses and a lab coat

Avid Bioservices

Mission, Vision, Purpose

Our Mission

To help biopharmaceutical companies bring complex, innovative therapies to market by providing specialized biologics development and CGMP manufacturing services that are faster, more reliable, and more deeply integrated than anything else in the industry.

Our Vision

To be the most trusted dedicated biologics CDMO in the United States the partner that biotech and pharma companies choose when the stakes are highest and the science is most demanding.

Our Purpose

Every molecule we develop. Every process we design. Every batch we manufacture. At the end of every program is a patient waiting for a therapy that didn’t exist before. That’s why this work matters and why we take it seriously.

The Avid Effect

“Discover the Avid effect” isn’t a tagline, it’s a promise. It’s what happens when unrivaled expertise, world-class facilities, exceptional quality, and a genuinely personalized process come together in service of a single goal: your molecule becoming a medicine that reaches patients.

1993

Began biologics development and manufacturing as Peregrine Pharmaceuticals

2002

Formed Avid Bioservices, Inc. as a wholly owned subsidiary of Peregrine Pharmaceuticals

2005

Received first FDA commercial approval

2016

Commissioned mammalian protein CGMP Drug Substance Tustin Line 2 facility

2018

Avid Bioservices Inc. launched as a dedicated, independent biologics manufacturer (NASDAQ:CDMO)

2023

Commissioned mammalian protein CGMP Drug Substance Tustin Line 3 facility

2025

Avid Bioservices Inc. acquired by GHO Capital Partners and Ampersand Capital Partners

2026

Opened Early-Phase Center of Excellence

Female scientist wearing safety glasses and a lab coat in front of laboratory equipment

OUR PEOPLE

Expertise that Drives Every Program

Avid’s team includes scientists, engineers, and quality professionals with deep biologics expertise and long tenure.

What sets our team apart is not just technical knowledge, it’s how we work:

Scientific depth: specialized expertise across disciplines

Quality mindset: built into every action

Transparency: clear, real-time communication

Accountability: ownership of outcomes

Continuity: long-term team stability

Patient focus: purpose behind every decision

Scientist in a lab coat operating large bioprocessing equipment with tubing

Quality

Quality at Our Core

Quality is not a checkpoint, it’s how we operate.

Our integrated quality systems support development, manufacturing, and regulatory readiness across the full program lifecycle backed by a proven inspection track record and decades of experience.

Tell us about your molecule, your stage, and your goals. We’re ready to help you get it
to patients.